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Summary
Macrophages play a central role in the development of atherosclerosis through the accumulation of oxidized LDL (oxLDL).
AIM (Spα/Api6) has previously been shown to promote macrophage survival; however, its function in atherogenesis is
unknown. Here we identify AIM as a critical factor that protects macrophages from the apoptotic effects of oxidized lipids.
AIM protein is induced in response to oxLDL loading and is highly expressed in foam cells within atherosclerotic lesions.
Interestingly, both expression of AIM in lesions and its induction by oxidized lipids require the action of LXR/RXR hetero-
dimers. AIM−/− macrophages are highly susceptible to oxLDL-induced apoptosis in vitro and undergo accelerated apopto-
sis in atherosclerotic lesions in vivo. Moreover, early atherosclerotic lesions in AIM−/−LDLR−/− double knockout mice are
dramatically reduced when compared to AIM+/+LDLR−/− controls. We conclude that AIM production facilitates macrophage
survival within atherosclerotic lesions and that loss of AIM decreases early lesion development by increasing macro-
phage apoptosis.Introduction
Macrophages play a crucial role in the development of athero-
sclerosis (Lusis, 2000; Glass and Witztum, 2001; Li and Glass,
2002). During the initial stages of the disease, monocytes mi-
grate from the blood into the subendothelial space of the blood
vessel and differentiate into macrophages. Under hyperlipid-
emic conditions, these macrophages incorporate highly oxi-
dized low-density lipoprotein (oxLDL) and accumulate choles-
teryl ester lipid droplets. This uptake of oxLDL by macrophages
is mainly mediated by two “scavenger receptors,” SR-A and
CD36, and mice lacking either or both of these receptors show
a reduction in atherosclerosis (Suzuki et al., 1997; Febbraio et
al., 2000). Such “foam cells” are the hallmark for both the fatty
streak and the more advanced atherosclerotic lesions that may
subsequently develop.
OxLDL is known to exert cytotoxic effects and to induce
apoptosis in various cell types including macrophages (Sal-
vayre et al., 2002), and hence, the environment within lesions
is extremely proapoptotic (Geng and Libby, 2002). The conse-
quences of macrophage apoptosis during different stages of
atherosclerosis have remained unclear (Libby et al., 1996; Mal-
lat et al., 1999; Kolodgie et al., 2000; Kockx and Herman, 2000;
Geng and Libby, 2002; Littlewood and Bennett, 2003; Tabas,
2004). During the late disease stages, pathological studies of
advanced atherosclerotic lesions have revealed a strong corre-
lation between macrophage apoptosis and large necrotic cores
on the one hand and the incidence of plaque rupture and acuteCELL METABOLISM : MARCH 2005 · VOL. 1 · COPYRIGHT © 2005 ELSEvascular events on the other. These observations imply that the
apoptotic death of the mature foam macrophages during the
late stage may accelerate plaque destabilization, which is
probably responsible for acute atherothrombotic vascular oc-
clusion and tissue infarction (Tabas, 2004). However, it remains
unclear as to how macrophage apoptosis influences the dis-
ease during the initiating and developing stages.
Cholesterol accumulation caused by incorporation of oxLDL
in macrophages is known to activate the nuclear receptor LXR,
which induces genes such as ABCA1, ApoE, and ABCG1 that
facilitate the efflux of lipoprotein-derived cholesterol and re-
verse cholesterol transport (Chawla et al., 2001; Edwards et al.,
2002; Tontonoz and Mangelsdorf, 2003). Recent works have
established that AIM (apoptosis inhibitor expressed by macro-
phages; also called Spα or Api6) (Gebe et al., 1997; Miyazaki
et al., 1999) expression is also induced by activation of LXR/
RXR heterodimers (Maxwell et al., 2003; Joseph et al., 2004;
Valledor et al., 2004), though the relevance of this AIM gene
regulation to the response to oxidized lipids has not been ad-
dressed. AIM is a member of the scavenger receptor cysteine-
rich superfamily (SRCR-SF) and is specifically produced by
mature tissue macrophages (Miyazaki et al., 1999). AIM sup-
ports the survival of macrophages themselves against different
apoptosis-inducing stimuli (Miyazaki et al., 1999; Kuwata et al.,
2003). Consistently, recent studies have implicated AIM in pro-
tection of macrophages from the apoptotic effects of bacterial
pathogens such as Listeria monocytogenes (Joseph et al., 2004),
Bacillus anthracis, Escherichia coli, and Salmonella typhimuriunVIER INC. DOI 10.1016/j.cmet.2005.02.002 201
A R T I C L EFigure 1. Induction of the AIM expression by oxLDL
via LXR/RXR activation
A) Induction of AIM protein expression by LXR ago-
nist in RAW-LXRα macrophages. RAW-LXRα cells
(RAW264.7 cells stably transfected with an LXRa-
retrovirus vector) were incubated with 1 M of non-
selective LXR agonist GW3965 or vehicle (DMSO)
for 24 hr. Cells were stained with anti-AIM antibody
(red) and anti-CD68 (macrophage maker, green).
Objective magnification: ×5.
B) Northern blot analysis for AIM mRNA. As we pre-
viously reported (Miyazaki, et al., 1999), the pre-cul-
ture of thioglycollate-induced mouse peritoneal ma-
crophages diminished native AIM expression (Lane
1: None). Macrophages were then incubated for 24
hr in the presence of either oxLDL (50 g/ml), LDL
(50 g/ml), or a mixture of 5 M of T0901317 (indi-
cated as T) and 100 nM of LG100153 (LG).
T0901317 is a LXR agonist, whereas LG100153 is a
RXR agonist. Data were normalized according to the
expression of b-actin mRNA (lower panel). The re-
presentative result from four sets of experiment is
presented.
C) QPCR was also performed using the RNA sam-
ples in (B). Three sets of experiments were per-
formed, and the means ± SEM are presented. Data
are described as relative expressions of AIM mRNA
normalized to 36B4 mRNA.
D) Macrophages isolated from wild-type (LXRab+/+)
or LXRab−/− mice were incubated with either DMSO
(control: blue bars), 4 g/ml of oxysterol (22R-
hydroxycholesterol [22R]: yellow bars), 100 nM of
RXR agonist (LG268[LG]: green bars), or a mixture
of LG and 22R (orange bars). After a 16 hr incuba-
tion, AIM mRNA expression levels were analyzed by
QPCR (n = 3). Data are described as relative expres-
sions of AIM mRNA normalized to 36B4 mRNA.
E) AIM protein expression in liver macrophages
(Kupffer cells). Serial frozen liver sections from B6
mice maintained for 2 weeks with normal chow,
Western diet, normal chow containing T0901317
(0.1% w/w) (from left to right), or from AIM−/− mice
fed with normal chow containing T0901317 (0.1%
w/w) for 2 weeks were stained for F4/80 (upper; red
signals) or AIM (lower; green signals). Objective
magnification: ×10.(Valledor et al., 2004). The fact that AIM mRNA is induced by
LXR/RXR provokes the hypothesis that AIM may also be pro-
duced in lipid-laden macrophages at atherosclerosis lesions,
and this induction might support the survival of macrophages
within the lesions. Thus, AIM might play a role in atherosclero-
genesis.
In this report, we first investigated AIM induction in macro-
phages in response to oxidative lipids. Secondly, we studied
the AIM expression in macrophages within atherosclerotic
lesions. Thirdly, we determined the influence of the lack of AIM
on macrophage apoptosis within the lesions by generating
mice doubly deficient for both AIM and the LDL receptor
(LDLR: Herz et al., 1992). Finally, we addressed how the loss
of AIM alters the course of atherosclerosis development.
Results
Incorporation of oxLDL increases AIM expression
in macrophages via LXR/RXR activation
Recently, several groups have reported that AIM mRNA is
markedly induced in macrophages when cells are incubated202with agonists for the LXR/RXR heterodimer (Maxwell et al.,
2003; Joseph et al., 2004; Valledor et al., 2004; our unpub-
lished data). Furthermore, Joseph et al. demonstrated that the
AIM gene is a direct target of LXR/RXR heterodimers: LXRα/
RXR binds to the LXRE, which exists at position −5471 w
−5486 (from the ATG start site) in the AIM promoter region (Jo-
seph et al., 2004). Based on these results, we confirmed the
induction of AIM expression via LXR/RXR at the protein level
by employing RAW264.7 macrophages that stably expressed
LXRα from a retroviral expression vector (Venkateswaran et al.,
2000; Joseph et al., 2004). As shown in Figure 1A, intracellular
staining for AIM using an anti-AIM polyclonal antibody, SA-1,
revealed that production of AIM protein is highly induced in
RAW264.7-LXRα cells in the presence of the nonselective LXR
agonist, GW3965 (1 M) (Collins et al., 2002).
The regulation of AIM via LXR/RXR suggested that incorpo-
ration of oxLDL that yields oxysterols, the native ligands of LXR,
may also upregulate AIM expression in macrophages. We
tested this possibility by Northern blotting (Figure 1B) and real-
time quantitative RT-PCR (QPCR: Bookout and Mangelsdorf,
2003) (Figure 1C) using RNA isolated from thioglycollate-inducedCELL METABOLISM : MARCH 2005
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g/ml), oxLDL (50 g/ml), or a mixture of agonists of LXR or
RXR (T0901317 [5 M] and LG100153 [100 nM], respectively).
As expected, incubation of macrophages with oxLDL, but not
native LDL, resulted in a significant increase of AIM mRNA. The
mixture of T0901317 and LG100153 revealed a higher induc-
tion of AIM mRNA than did oxLDL. This was also the case for
other downstream genes such as ApoE, ABCA1, and ABCG1,
according to a previous report: direct activation of LXR/RXR
via their agonists induced the mRNA expression of these genes
more efficiently than oxLDL (Laffitte et al., 2001). Furthermore,
we also assessed AIM expression induction in macrophages
isolated from mice devoid of both LXRα and β receptors
(LXRab−/−) (Peet et al., 1998). As shown in Figure 1D, QPCR
analysis detected no AIM mRNA induction in LXRab−/− macro-
phages after incubation with either oxysterol, a RXR agonist,
or a mixture of both, corroborating that AIM expression regula-
tion by oxidative lipids is mediated by LXR/RXR.
In addition to the in vitro analysis, we also assessed whether
AIM protein expression is induced in vivo through LXR, by
using immunohistochemistry with the SA-1 antibody. Since the
liver macrophages (Kupffer cells) potentially express AIM (Miy-
azaki et al., 1999; Kuwata et al., 2003), we examined the liver
sections from wild-type (C57BL/6 [B6]) mice following admin-
istration for 2 weeks of normal chow, a high-fat Western diet
(containing 1.25% cholesterol), or normal chow containing
T0901317 (0.1% w/w). In line with the in vitro results presented
above, the number of AIM expressing Kupffer cells (stained
with the F4/80 [pan-macrophage] antibody), and the intensity
of AIM staining in each cell, strikingly increased after challenge
with either the Western diet or T0901317 (Figure 1E). To ex-
clude the possibility of an antibody-staining artifact, we stained
the liver of AIM-deficient (AIM−/−) mice (Miyazaki et al., 1999)
fed with chow containing T0901317. No AIM staining was
detected in the Kupffer cells from these mice (Figure 1E), con-
firming the specificity of AIM staining. Reflecting the macro-
phage-specific expression of the AIM gene (Miyazaki et al.,
1999), neither the Western diet nor T0901317 induced AIM ex-
pression in hepatocytes, where instead LXR activation strongly
promotes the production of other downstream elements con-
trolling the bile acid and cholesterol biosynthetic pathways (Ja-
nowski et al., 1996; Peet et al., 1998; Repa and Mangelsdorf,
2000). Together, all these results demonstrate that oxidized lipids
regulate macrophage AIM expression both in vivo and in vitro.
AIM is highly expressed in macrophages
within atherosclerotic lesions
Macrophages within atherosclerotic lesions take up oxLDL and
accumulate intracellular cholesteryl esters. Hence, the induc-
tion of AIM expression by oxidative lipids via LXR/RXR sug-
gests that the lipid-loaded macrophages found within athero-
sclerotic lesions may express AIM. To test this possibility, we
examined by using immunohistochemistry the atherosclerotic
plaques that developed in the aortic root of LDLR−/− mice fed
a high-fat Western diet. The atherosclerotic plaques in mice
fed in such a manner for 12 weeks contained numerous lipid-
filled macrophages, which stained positively with both Oil RedCELL METABOLISM : MARCH 2005O (Figure 2A, upper lane) and F4/80 (Figure 2A, lower lane).
These same macrophages also stained with antibody to AIM
(Figure 2A, middle lane). In addition, as demonstrated in Figure
2B, AIM production was detected in macrophages present in
the precursor of atherosclerotic lesions, which developed in
mice challenged with the diet for a shorter period of 5 weeks.
The intensity of AIM staining in the lesions was comparable in
mice after both the 5-week and the 12-week diet. Also, within
the lesions, AIM production is specific to macrophages and
could not be detected in either the CD31+ endothelial cells
(Figure 2C, upper) or α-actin+ smooth muscle cells (SMCs; Fig-
ure 2C, lower). As the SA-1 antibody reacts with both mouse
and human AIM proteins, we also stained a human specimen
containing atherosclerosis lesions (human left anterior de-
scending coronary artery). Figure 2D confirmed that high levels
of AIM protein are also expressed in human lesions. In addition,
to corroborate the AIM expression regulation by LXR/RXR in
lesions, we examined for expression of the AIM protein the
lesions developed in apolipoprotein E-null (ApoE−/−) mice that
had been transplanted with bone marrow cells isolated from
LXRab−/− mice. In these mice, the vast majority of the lesional
macrophages were derived from LXRab−/− mice (Tangirala et
al., 2002). Remarkably, the AIM protein was virtually undetecta-
ble in lesions of these mice, in contrast to control ApoE−/− re-
cipients transplanted with autologous (LXRab+/+) bone marrow
cells (Figure 2E). This result is consistent with the previous data
showing that AIM expression in hepatic and splenic macro-
phages is dependent on LXR (Joseph et al., 2004).
AIM supports the survival of macrophages
within the lesions
Despite their vast exposure to oxLDL, lesional macrophages
are markedly resistant to apoptosis (Kolodgie et al., 2000;
Kockx and Herman, 2000; Geng and Libby, 2002; Littlewood
and Bennett, 2003). The substantial expression of AIM in ma-
crophages within lesions provokes the idea that AIM pro-
duction may play a role in increasing the resistance of macro-
phages to apoptosis. To this end, we first tested the efficacy
of AIM in supporting the survival of oxLDL-loaded macro-
phages in vitro. We compared the DNA fragmentation in ex
vivo macrophages freshly isolated from thioglycollate-activated
AIM-null (AIM−/−) and wild-type (AIM+/+) mice, after treating the
cells with various concentrations of oxLDL for 16 hr. In AIM+/+
macrophages, incubation with oxLDL resulted in a substantial
expression of AIM as confirmed by QPCR. (Figure 3A). As
shown in Figure 3B, AIM−/− macrophages harbored a larger
proportion of TUNEL+ cells after oxLDL treatment than did
AIM+/+ macrophages. Correlating with this observation, AIM+/+
macrophages demonstrated a greater viability after high-dose
oxLDL treatment than did AIM−/− macrophages: the number of
propidium iodide (PI)-stained cells was more than ten times
less (p < 0.01) in AIM+/+ macrophages than in AIM−/− macro-
phages after treatment (Figure 3C). Thus, AIM efficiently pro-
tects macrophages from oxLDL-induced apoptosis.
Next we directly tested the impact of removing AIM on mac-
rophage survival within the lesions in vivo. We generated
double knockout mice for both AIM and LDLR (AIM−/−LDLR−/−)
and examined the number of apoptotic macrophages within
the atherosclerotic lesions that developed after maintaining the
mice on a high-cholesterol atherogenic diet for 5 or 12 weeks.
As predicted, a far larger number of TUNEL+ cells were ob-203
A R T I C L EFigure 2. Macrophages within the atherosclerotic lesions of LDLR−/− mice express AIM
Atherosclerotic lesions at the aortic root from LDLR−/− mice challenged with a high-fat Western diet for 12 weeks (A) or 5 weeks (B) were analyzed for AIM expression
by immunohistochemistry. Serial sections were stained with Oil Red O (upper), AIM (middle; green signals), or pan-macrophage antigen F4/80 (lower; red signals).
Objective magnifications are ×4 for figures in the left lane and ×20 in the right lane both for panels (A) and (B). NC: necrotic core. Control staining of the sections with
only secondary antibody (Alexa Fluor 488-conjugated goat anti-rabbit IgG polyclonal antibody or Cy3-conjugated anti-rat IgG polyclonal antibody) did not yield
any signals.204 CELL METABOLISM : MARCH 2005
Deletion of AIM decreases atherosclerosis developmentserved within the F4/80+ macrophage-rich area in the lesions
of AIM−/−LDLR−/− mice than in those of AIM+/+LDLR−/− litter-
mate mice after a 12-week diet (Figure 3D). In mice challenged
with the high-fat diet for a shorter period (5 weeks), almost no
TUNEL+ apoptotic cells were detected within the lesions in
AIM+/+LDLR−/− mice, whereas many TUNEL+ cells were pre-
sent in AIM−/−LDLR−/− mice (Figure 3E). When quantified, the
number of apoptotic cells in an area of 1 × 104 m2 was more
than 25 times (after a 12-week diet) or 40 times (after a 5-week
diet) larger in AIM−/−LDLR−/− mice than in AIM+/+LDLR−/− con-
trols (Figure 3F; p < 0.01). No obvious increase in TUNEL+ cells
in α-actin+ SMC areas (the corresponding areas are indicated
by yellow arrows in TUNEL panels) was detected in AIM−/−
LDLR−/− mice, indicating the lack of effect of AIM on SMCs
(Figures 3D and 3E). Altogether, we conclude that the pro-
duction of AIM is an important mechanism responsible for
increasing the ability of macrophages to survive within athero-
sclerotic lesions.
Deletion of AIM decreases
the atherosclerosis development
Next we investigated whether AIM might play a role in the
pathogenesis of atherosclerosis by supporting survival of
lesional macrophages. In order to address whether deletion of
AIM may decrease or accelerate the disease, we statistically
analyzed the size of the lesions that developed in AIM−/−
LDLR−/− and AIM+/+LDLR−/− littermate mice. The mice used in
this experiment had been backcrossed to B6 strain for several
generations. In addition, to further eliminate the influence of
different genetic backgrounds (129 versus B6) on the incidence
of atherosclerosis, prior to phenotyping the mice, we typed the
genomic DNA from all the mice using MIT-reliable genetic
markers that distinguish between the 129 and B6 strains (de-
tails described in Experimental Procedures) (Kelly et al., 2003).
Thereafter, we analyzed the atherosclerosis development only
in the mice that were homozygous for the B6 alleles (B6/B6) in
all the analyzed genetic loci. Finally, we examined 16 geneti-
cally equivalent mice (8 males and 8 females) for each group
after 5- and 12-week high-fat diets.
Both AIM−/−LDLR−/− and AIM+/+LDLR−/− littermate mice
showed comparable serum cholesterol levels after consump-
tion of a high-cholesterol diet for either 5 or 12 weeks (Figure
4A), which clearly excludes the influence of possible differ-
ences in cholesterol profiles on the disease initiation and pro-
gression between the two types of mice. Supporting this, re-
moval of cholesterol from macrophages was not affected by
the lack of AIM. We addressed the ApoAI-specific cholesterol
efflux efficiency in AIM−/− and AIM+/+ bone marrow-derived
macrophages and found it to be equivalent in both types of
cells (Figure 4B). Consistent with this result, expression of phages with lipopolysaccharide (LPS; 100 ng/ml) for 5 hr and
C) Lesions that developed in LDLR−/− mice after the 12-week diet were stained with anti-AIM (green signals), anti-CD31 for the vascular endothelial cells (VEC) (red
signals, indicated by white arrows), or anti-α actin for SMCs (red signals, indicated by yellow arrows). No AIM expression was detected in endothelial cells or SMCs.
Objective magnification: ×20.
D) Expression of AIM in human atherosclerotic lesions. Human left anterior descending coronary artery containing atherosclerotic plaque was stained for both AIM
(with the SA-1 antibody) and DAPI (blue signals). The human AIM protein is detected as the green signal (left panels). Staining with nonimmune rabbit IgG is served as
a negative control (right panels). Objective magnifications: ×5 (upper panels), ×15 (lower panels).
E) LXR-dependent expression of AIM protein in macrophages within aortic lesions. Aortic root sections from ApoE−/− mice transplanted with either ApoE−/− control or
LXRab−/− bone marrow cells were analyzed for AIM (red signals, upper) and MOMA-2 (green signals, lower) protein expression by fluorescence immunostaining.
Sections were counterstained with DAPI (blue). Objective magnification: ×5.CELL METABOLISM : MARCH 2005the ABCA1 transporter gene was also similar in AIM−/− and
AIM+/+ bone marrow-derived macrophages (Figure 4C). More-
over, the number of blood monocytes, which might also influ-
ence the lesion development, was similar in AIM−/−LDLR−/− and
AIM+/+LDLR−/− littermate mice (1.5 ± 0.2 × 105/ml in AIM−/−
LDLR−/− versus 1.6 ± 0.5 × 105/ml in AIM+/+LDLR−/−; n = 7
each). No significant difference was observed in mice with or
without the diet.
Interestingly, lesion development at the aortic root was mark-
edly decreased in AIM−/−LDLR−/− mice as compared to
AIM+/+LDLR−/− littermate mice (AIM+/+LDLR−/− versus AIM−/−
LDLR−/−: 26.2 ± 9.5 versus 3.1 ± 2.7 after the 5-week diet; 62.2 ±
7.2 versus 16.8 ± 4.2 after the 12-week diet [m2 × 104]; p <
0.01) (Figures 4D and 4E). Diminished atherosclerosis in the
absence of AIM was also found along the length of the aorta
when analyzed en face. As shown in Figure 4F, in AIM−/−
LDLR−/− mice, the staining of atherosclerotic lesions with Oil
Red O was remarkably less than in AIM+/+LDLR−/− mice after
a 12-week diet. Conspicuously, the abdominal aorta was
largely free of disease in most AIM−/−LDLR−/− mice, which was
in contrast to the substantial lesion formation observed in all
of the AIM+/+LDLR−/− mice (boxed area in Figure 4F). When
quantified in the abdominal aorta region, the lesions stained
by Oil Red O were up to 20 times smaller in size in AIM−/−
LDLR−/− mice as compared to AIM+/+LDLR−/− controls (Figure 4G).
Immunohistological detection of macrophages and macro-
phage foam cells, using the F4/80 antibody, showed greatly
reduced staining for these cells in lesions at the aortic roots of
AIM−/−LDLR−/− mice as compared to those of AIM+/+LDLR−/−
littermate mice (Figure 5A; F4/80). Statistical analysis of F4/80+
area revealed its significant decrease in AIM−/−LDLR−/− mice as
compared to AIM+/+LDLR−/− littermate mice (Figure 5B), clearly
indicating that the lesion diminishment in the absence of AIM
(shown in Figures 4D and 4E) is mainly due to decrease of
lesional macrophages. In accordance with such less advanced
lesion development, immunohistological characterization of se-
lected lesions also revealed some decreased levels of smooth
muscle α-actin and collagen in AIM−/−LDLR−/− mice (Figure 5A,
α-actin and collagen, respectively).
Increased macrophage death secondarily reduces
the inflammatory state within lesions
Since macrophage is an important regulator of inflammation
and it is well established that the lesional inflammation also
plays a key role in acceleration of atherosclerosis (Lusis, 2000;
Glass and Witztum, 2001; Li and Glass, 2002; Geng and Libby,
2002; Libby, 2002), we tested if the lack of AIM might also
influence the inflammatory responses in macrophages. We
challenged AIM−/− and AIM+/+ bone marrow-derived macro-205
A R T I C L EFigure 3. Deletion of AIM Increases apoptosis of
macrophages within the atherosclerotic lesions
A–C) AIM inhibits oxLDL-induced apoptosis in ma-
crophages. A and B) Peritoneal macrophages freshly
isolated from AIM−/− (black boxes) or wild-type
AIM+/+ mice (white boxes) were incubated with the
indicated concentrations of oxLDL for 16 hr. A) Total
RNA was isolated from cells after the incubation,
and the AIM expression was tested by QPCR. Rela-
tive AIM mRNA expression levels in cells incubated
with oxLDL at 100 g/ml are presented (n = 3 in
each group). Similar results were obtained from cells
incubated with oxLDL at other concentrations (data
not shown). The values were normalized to 36B4
mRNA. ND: not detected. B) Cells were harvested,
and the proportions of TUNEL+ macrophages were
estimated by flow cytometry. Data are presented as
the means of three independent experiments ±
SEM. C) AIM−/− (black box) or AIM+/+ (white box)
macrophages were treated with oxLDL at 300 g/
ml for 24–28 hr. Cells were harvested, and the pro-
portions of PI+-dead macrophages were determined
by flow cytometry. Data are presented as the means
of three independent experiments ± SEM.
D and E) Increased number of apoptotic cells at
atherosclerotic lesions in AIM−/−LDLR−/− mice. Se-
rial paraffin-embedded sections of lesions at the
aortic valve developed in AIM+/+LDLR−/− or AIM−/−
LDLR−/− mice after a 12-week (D) or 5-week (E)
Western diet were stained for AIM (upper; green sig-
nals), F4/80 (second lane; red signals), or TUNEL
(third lane; green signals). Far fewer numbers of
TUNEL+ cells were observed in AIM+/+LDLR−/− (in-
dicated by white arrows). The lower panels present
the α-actin staining of AIM−/−LDLR−/− sections for
SMCs. No increase of TUNEL+ cells was observed
in SMC regions (indicated by yellow arrows in
TUNEL panels) in AIM−/−LDLR−/−. Objective magni-
fication: ×10.
F) Numbers of TUNEL+ cells per 1 × 104 m2 were
quantified. White boxes, AIM+/+LDLR−/− mice; black
boxes, AIM−/−LDLR−/− mice. Data are presented as
the means of three independent areas at the aortic
valve region from ten different mice for each type of
mice. Error bars: SEM.206 CELL METABOLISM : MARCH 2005
Deletion of AIM decreases atherosclerosis developmentassessed the expression induction of various proinflammatory
genes, i.e., iNOS, IL-1b, IL-6, and MCP-1, by QPCR. As shown
in Figure 6A, no significant difference in expression levels of
such proinflammatory genes was observed in AIM−/− and
AIM+/+ macrophages after LPS stimulation, suggesting that
AIM has little direct role in the regulation of inflammatory re-
sponses in macrophages. Induction of proinflammatory gene
expression was markedly depressed by addition of LXR ago-
nists, consistent with the previous work (Joseph et al., 2003).
Despite the no direct role of AIM in the regulation of inflam-
matory responses in macrophages, the increased apoptotic
death of macrophages on an AIM−/− background may second-
arily reduce the inflammatory status of the plaques. We tested
this hypothesis by measuring the VCAM-1-expressing areas in
lesions. It is well known that VCAM-1 expression by SMCs is
a characteristic feature of atherosclerosis, which reflects the
inflammatory state in the plaque (Cybulsky and Gimbrone,
1991; Libby, 2002; Tupin et al., 2004). As expected, VCAM-1-
expressing cells were apparently less in AIM−/−LDLR−/− mice
than in AIM+/+LDLR−/− littermate mice (Figure 6B).
Discussion
A role of AIM in atherosclerosis development
The current findings are important for a variety of reasons.
Firstly, oxidative lipids induce AIM expression, and hence AIM
is highly expressed in macrophages within atherosclerotic
lesions. Secondly, the absence of AIM accelerates the apo-
ptotic death of macrophages within the lesions. Thus, AIM pro-
duction appears to be an important mechanism that supports
the macrophage survival within the lesions against the toxic
effects of oxLDL. Thirdly, deletion of AIM decreases atheroscle-
rosis development. Based on these observations, we summa-
rize in Figure 7 the putative role of AIM in atherosclerosis de-
velopment. During the early disease stages, following the
incorporation of oxLDL, macrophages accumulate the free
cholesterol droplets within the cells and mature into foam cells
(upper left panel). Although this process is highly proapoptotic
for the cells, AIM production via LXR/RXR activation protects
cells from prompt death, which allows macrophages to harbor
a large amount of cholesterol droplets. These long-surviving
mature foam cells accumulate within the intima and hence pro-
mote the expansion of the lesions (lower left panel). In the ab-
sence of AIM, however, macrophages are more susceptible to
apoptosis in response to oxLDL loading. This fast apoptotic
death consequently interferes with both maturation and accu-
mulation of the foam macrophages within the lesions (upper
right panel). Such responses during the early disease stages
result in a less progressive growth of the lesions (lower right
panel). The putative protective role of macrophage apoptosis
in early lesion development was also supported by the recent
observation in knockout mice of a proapoptotic element Bax
(Liu et al., 2005). Liu et al. reported an acceleration of the
plaque development in LDLR−/− mice that had been reconstitu-
ted with Bax−/− bone marrow cells. Since AIM is specifically
expressed in macrophages as we previously established (Miya-
zaki et al., 1999), the analysis of AIM−/−LDLR−/− mice should
precisely tell the effect of macrophage-specific diminishment
of AIM in atherosclerosis development. Nevertheless, the alter-
native type of experiment via transplantation of bone marrow
cells from AIM−/− mice into LDLR−/− mice, like the above ex-CELL METABOLISM : MARCH 2005periment by Liu et al., would further strengthen our observation
in a direct manner and thus might need to be considered as a
future experiment.
In addition to AIM induction, Valledor et al. recently reported
that LXR/RXR activation induces the expression of other anti-
apoptotic regulators such as Bcl-XL and Birc1a and, con-
versely, inhibits expression of proapoptotic elements, including
caspases 1, 4/11, 7, and 12; Fas ligand; and Dnase1l3 (Valledor
et al., 2004). Therefore, in response to oxLDL incorporation,
macrophages appear to protect themselves from apoptosis by
activating a series of antiapoptotic pathways. Nevertheless,
the marked acceleration of lesional macrophage apoptosis in
AIM−/−LDLR−/− mice is consistent with a predominant role for
AIM in this response. Since AIM is a secreted molecule, it could
potentially trigger some antiapoptotic signaling cascade(s).
Thus, it is possible that some of those intracellular apoptosis-
related elements induced by LXR might be downstream of AIM.
Further studies will be needed to address this possibility.
Macrophages deficient for scavenger receptors, such as
SR-A or CD36, are also less efficient in accumulating choles-
terol droplets due to defective uptake of oxLDL. Importantly, the
knockout mice of either receptor (when crossed to LDLR−/− or
ApoE−/− mice) also revealed a decrease in atherosclerosis de-
velopment (Suzuki et al., 1997; Febbraio et al., 2000). There-
fore, reduced cholesteryl ester accumulation due to either inef-
ficient oxLDL uptake (in SR-A−/− or CD36−/− mice) or the rapid
death of macrophages (in AIM−/− mice) results in reduction in
lesion size during early and developing disease stages. Note
that the absence of AIM does not influence the uptake of
oxLDL. We tested this by comparing the incorporation of Dil-
labeled oxLDL (Dil-oxLDL) by AIM+/+ and AIM−/− macrophages.
Both types of macrophages revealed an equivalent uptake of
Dil-oxLDL as assessed by flow cytometry (data not shown).
Although AIM has no direct role in regulation of inflammatory
activities of macrophages (as shown in Figure 6A), decreased
survival of macrophages may secondarily result in a decrease
in levels of macrophage-derived proinflammatory elements within
lesions (Figure 7; red arrows emerging from macrophages in
lower panels). Consequently, the inflammatory state at the
lesion, including proliferation of SMCs and their VCAM-1 ex-
pression levels (indicated in Figure 7, lower panels, also refer
to Figures 5A and 6B), appears to be less activated in AIM−/−
LDLR−/− mice than in AIM+/+LDLR−/− controls. This decreased
inflammation may further contribute to the reduction in athero-
sclerotic development, as it is well established that the inflam-
mation also plays a key role in disease acceleration (Lusis,
2000; Glass and Witztum, 2001; Li and Glass, 2002; Geng and
Libby, 2002; Libby, 2002). Furthermore, Cai et al. recently re-
ported an important role of endothelial VCAM-1 expression in
supporting monocyte survival against apoptosis via increasing
antiapoptotic kinase Akt and enhancement of Bcl-2 expression
(Cai et al., 2004). Thus, such secondary reduction of lesional
inflammation in the absence of AIM might further increase the
susceptibility of monocytes/macrophages to apoptosis.
AIM, LXR, and atherosclerosis
Paradoxically, although expression of AIM in lesional macro-
phages is strictly dependent on LXR activity, loss of AIM and
loss of LXR have opposite effects on lesion development in
mice: i.e., whereas loss of bone marrow LXRα and LXRβ ex-
pression accelerates atherosclerosis (Tangirala et al., 2002),207
A R T I C L EFigure 4. AIM deletion decreases development of atherosclerosis
A) Deletion of AIM does not influence serum cholesterol profiles. Serum cholesterol profiles of AIM+/+LDLR−/− and AIM−/−LDLR−/− mice after 5 or 12 weeks on a 1.25%
cholesterol diet. Data are presented as means of 12 mice analyzed for each group. Error bars: SEM.
B) Cholesterol efflux assay. ApoAI-dependent cholesterol efflux from AIM+/+ and AIM−/− bone marrow-derived macrophages treated with vehicle (DMSO [D]: blue bars)
or LXR/RXR agonists (2 M GW3965 and 100 nM LG268 [GL]: yellow bars). ApoAI-specific effluxes (left) and their relative folds over own DMSO control (right) are
presented. No significant difference in efflux was observed in AIM+/+ and AIM−/− cells. Error bars: SEM.
C) ABCA1 gene expression in AIM+/+ and AIM−/− bone marrow-derived macrophages treated with vehicle (DMSO [D]: blue bars) or LXR/RXR agonists (GL: yellow
bars). Again, no significant difference in ABCA1 levels was observed in AIM+/+ and AIM−/− cells. Error bars: SEM.
D and E) Frozen sections from the aortic roots of AIM+/+LDLR−/− or AIM−/−LDLR−/− mice maintained on a high-fat Western diet for 5 or 12 weeks were stained with Oil
Red O, and the lesions at the aortic valve were quantified. D) Representative histological data of the aortic valve area from mice after a 12-week diet (Objective
magnification: ×10). E) Scatter plots showing means of lesion size (m2). Each symbol represents the measurement from a single mouse (square, male; circle, female).
Sixteen mice (eight males and eight females) for each group were analyzed. All mice analyzed were homozygous for the B6 alleles (B6/B6) in all the genetic loci
analyzed by 22 MIT genetic markers (details are described in Experimental Procedures).
F) Representative photographs from en face analysis of aortas from AIM+/+LDLR−/− (left) and AIM−/−LDLR−/− (right) mice after 12 weeks on a Western diet. Ten mice
(five males and five females) for each group were analyzed. In AIM+/+LDLR−/− mice, the abdominal aorta (boxed area) was severely affected.
G) Scatter plots showing means of lesion size in the abdominal aorta region (mm2). Each symbol represents the measurement from a single mouse (square, male;
circle, female). Ten mice (five males and five females) for each group were analyzed.mice lacking AIM are protected. This discrepancy is most likely
related to the fact that, as a transcription factor, LXR regulates
the expression of many genes in addition to AIM, each of which
may impact lesion development (e.g., ABCA1, ABCG1, ApoE,208PLTP) (Tontonoz and Mangelsdorf, 2003). The antiapoptotic ef-
fect of AIM contrasts with these other LXR/RXR-dependent
gene effects that are protective against the disease via removal
of cholesterol from macrophages (Plump et al., 1992; GroenCELL METABOLISM : MARCH 2005
Deletion of AIM decreases atherosclerosis developmentFigure 5. Decreased macrophages in number within lesions of AIM−/−LDLR−/− mice
A) Representative photographs of aortic sinuses from AIM+/+LDLR−/− and AIM−/−LDLR−/− mice stained with Oil Red O, antibody to either macrophage F4/80 (red
signals), or α-actin for SMC (red signals; indicated by arrows), or with Picrosirus Red for type 3 collagen. Four serial sections from respective mice were used. NC:
necrotic core. AV: Aortic valve. Objective magnification: ×10.
B) F4/80-stained areas in the sections were quantified using image analysis software (NIH image 1.63). White boxes, AIM+/+LDLR−/− mice; black boxes, AIM−/−LDLR−/−
mice. Data are presented as the means of three independent sections at the aortic valve region from 16 different mice for each type of mice after a 5-week or 12-week
diet. Error bars: SEM.ulates expression of the AIM gene (Joseph et al., 2004), it isdata suggest that the critical role of LXR in cholesterol efflux
Figure 6. Decreased inflammation secondary to accelerated macrophage apoptosis in lesions of AIM−/−LDLR−/− mice
A) Macrophage inflammatory response. AIM+/+ and AIM−/− bone marrow-derived macrophages were treated with DMSO (blue bars), GW3965 + LG268 (yellow bars),
DMSO + LPS (green bars), or GW3965 + LG268 + LPS (orange bars). QPCR analysis was used to determine the expression of the indicated proinflammatory genes
and AIM (normalized to 36B4 mRNA). Data are represented as fold over DMSO control. Error bars: SEM.
B) Representative photographs of lesions for VCAM-1 expression. Lesions developed in AIM+/+LDLR−/− or AIM−/−LDLR−/− mice after 12 weeks on a Western diet were
stained for Oil Red O (upper) and VCAM-1 (lower: red signals). Objective magnification: ×10.et al., 2001). According to the observation by Valledor et al.
discussed above (Valledor et al., 2004), lesional macrophages
in LXRab−/− should also be less efficient in induction of other
antiapoptotic regulators and in suppression of proapoptotic
regulators and effectors. When viewed together, the presentCELL METABOLISM : MARCH 2005appears to be dominant in atherosclerosis development. Un-
controlled lipid accumulation in LXRab−/− macrophages in-
creases atherosclerosis susceptibility, despite the increased
rate of macrophage apoptosis.
Alternatively, based on the fact that the LXRα selectively reg-209
A R T I C L EFigure 7. A model for the putative role of AIM in
atherosclerosis development
Left: AIM+/+LDLR−/− mice. Incorporation of oxLDL
produces AIM in migrating macrophages via LXR/
RXR. This supports the survival of mature foam ma-
crophages, which harbor a large amount of choles-
terol droplets (upper panel). This response results in
accumulation of foam cells within intima, leading to
expansion of the lesions (lower panel). Blood mono-
cytes do not express AIM (Miyazaki et al., 1999;
Haruta et al., 2001). Right: AIM−/−LDLR−/− mice. In
contrast, in the absence of AIM, macrophages are
more susceptible to apoptosis in response to oxLDL
loading (upper panel). The fast apoptotic death con-
sequently interferes with both maturation and accu-
mulation of the foam macrophages, thus leading to
a less progressive growth of the lesions (lower
panel). Accelerated death of macrophages subse-
quently deceases the amount of proinflammatory
cytokines, which are yielded by macrophages (indi-
cated by red arrows), within the lesions. This may
reduce the proliferation of SMCs and the VCAM-1
expression levels by those cells (indicated by red-
stained cells).formally possible that LXRβ is atheroprotective (consistent with
accelerated disease on a LXRab−/− background [Tangirala et
al., 2002]), while LXRα may in fact be predominantly athero-
genic (consistent with decreased disease in the absence of
AIM). However, the ability of both LXRα and LXRβ to promote
cholesterol efflux from macrophages might argue against this
hypothesis. Further studies will be required to address these
issues.
At vulnerable plaques
It has been postulated that the apoptotic death of macro-
phages may increase the plaque instability, which is believed to
be responsible for atherothrombosis (Feng et al., 2003; Tabas,
2004). Therefore, deletion of AIM at vulnerable plaques during
the late disease stages might be detrimental for the cardiovas-
cular diseases, despite the fact that it is protective during the
early stages of lesion development. Although the LDLR−/−
model system has provided numerous important insights into
atherosclerosis, the fact that they contain relatively early
lesions compared to advanced human lesions makes them
poor models to study advanced plaque rupture. Therefore, it
may be difficult to adequately study the effect of AIM inactiva-
tion at vulnerable plaques in the model system used in this
report. To address this issue, further studies and the develop-
ment of more appropriate animal models will be required.
Experimental procedures
Mice
AIM−/−LDLR−/− double knockout mice were generated by crossing AIM−/−
and LDLR−/− (both were originally generated on a 129 × B6 background210and have been backcrossed to B6 for several generations). To avoid the
influence of the differences in the genetic background on disease incidence,
we used animals harboring the B6 genotype at 22 MIT genetic markers that
are polymorphic between the 129 and B6 strains (Kelly et al., 2003). The
markers tested are D1MIT48, D1MIT389, D2MIT237, D2MIT277, D2MIT224,
D4MIT27, D6MIT9, D6MIT36, D6MIT201, D8MIT211, D10MIT38,
D10MIT186, D11MIT20, D13MIT147, D13MIT35, D14MIT60, D15MIT29,
D15MIT14, D16MIT4, D17MIT93, D17MIT123, and D19MIT78. The genetic
analyses were performed by PCR using tail genomic DNA (Kelly et al.,
2003). In AIM−/−LDLR−/− mice, the AIM gene locus on chromosome 3 is
derived from the 129 strain (Miyazaki et al., 1999). However, no atheroscle-
rosis susceptibility locus so far identified has been linked to the genomic
region of the AIM gene (Paigen et al., 1989; Mehrabian et al., 2001; Welch
et al., 2001; Colinayo et al., 2002). To induce atherosclerosis, mice were fed
a high-fat Western diet containing 1.25% cholesterol (ICN Biomedicals Inc.)
for 5 or 12 weeks starting at 6–8 weeks of age. To generate bone marrow
chimera mice, recipient ApoE−/− mice (10 weeks of age) were lethally irradi-
ated with 900 rads (9 Gy) and transplanted with bone marrow cells (3 × 106)
from 8-week-old donor mice via tail vein injection as described (Tangirala
et al., 2002). All animals used in these experiments were cared for in accor-
dance with institutional guidelines and with institutional approval.
RNA analysis
Thioglycollate-induced peritoneal macrophages were prepared from B6
mice. Cells were cultured in DMEM medium containing lipoprotein-deficient
bovine serum (LPDS; Biomedical Technologies Inc.) for 48 hr to reduce AIM
expression (Miyazaki et al., 1999). Cells were then incubated for 24 hr in
the presence either of LDL, oxLDL, or a mixture of T0901317 (50 M) and
LG100153 (100 nM). Cells were harvested and RNA was assessed for AIM
or the control b-actin expression by Northern blotting using an AIM cDNA
fragment (the whole coding sequence: 1058 bp length) and a mouse
b-actin cDNA fragment (the whole coding sequence: 1127 bp length) asCELL METABOLISM : MARCH 2005
Deletion of AIM decreases atherosclerosis developmentprobes. The AIM mRNA levels were also examined by real-time quantitative
RT-PCR (QPCR) using ABI 7900HT (ABI) as described previously (Bookout
and Mangelsdorf, 2003). The AIM mRNA levels in macrophages from
LXRab−/− mice and wild-type control mice, after a stimulation either by
DMSO, LG268 (100 nM), 22R-hydroxycholesterol (4 g/ml), or a mixture of
both, were also tested by QPCR in the same way as above.
Lesion analysis
Lipid deposition was quantified as described (Tangirala et al., 1995). Briefly,
for en face aorta analyses, mice were sacrificed and the aortic tree was
perfused with heparin/PBS and then with 4% paraformaldehyde in PBS.
The aorta was isolated by severing minor branching arteries and dissecting
the adventitia. Fat tissue deposited outside the aorta was carefully and
completely removed. The specimen was removed en bloc from the root to
the iliac bifurcation and then opened by a longitudinal cut along the ventral
surface. After 12 hr of fixation in 4% paraformaldehyde, lipids were stained
with Oil Red O (Sigma). Stained aortas were taped to black paper, and
photographs were taken. The percentage of aortic area stained red was
determined using image analysis software (NIH image 1.63). For analysis of
aortic roots, perfused aortas were fixed in 4% paraformaldehyde in PBS for
16 hr followed by incubation in 10% sucrose for 24 hr or longer at 4°C.
Fixed aortas were frozen in OCT embedding medium. Starting at the aortic
valve area, 2–5 serial 6 m sections were cut at five loci with 25 m in-
tervals. One to two sections at each locus were stained with Oil Red O.
Identical aortic valve sites were analyzed in AIM+/+LDLR−/− and AIM−/−
LDLR−/− mice (16 mice [8 males and 8 females] for each strain). Stained
areas in the sections were quantified using image analysis software (NIH
image 1.63). All analyses were performed by two investigators blinded to
the genotype of the mice.
Apoptosis assay
Thioglycollate-induced peritoneal macrophages prepared from AIM−/− or
wild-type (AIM+/+) littermates were incubated with various concentrations of
oxLDL in DMEM culture medium containing 5% FCS in 12-well plates (106
cells/well) for 16 hr. DNA fragmentation in macrophages after incubation
with oxLDL was analyzed using the DeadEnd Fluorometric TUNEL System
(Promega). Proportions of TUNEL-positive cells were determined by flow
cytometry (FACSCalibure; Becton-Dickinson). Cell viability was assessed by
propidium iodide (PI) staining after incubating the cells with various concen-
trations of oxLDL for 24–28 hr. Cells were harvested and analyzed by flow
cytometry for PI-positive cells. To detect apoptotic cells in atherosclerotic
lesions, fixed aortic roots were paraffin-embedded and serial sections were
stained for TUNEL+ cells (by using the DeadEnd Fluorometric TUNEL Sys-
tem as above), AIM, or F4/80. LDL and oxLDL used for these experiments
were purchased from Biogenesis, INTRACEL, or Biomedical Technologies Inc.
Cholesterol efflux
Cholesterol efflux assays were performed in triplicate as described (Ven-
kateswaran et al., 2000). AIM+/+ and AIM−/− bone marrow-derived macro-
phages were labeled with [3H]cholesterol (1.0 Ci/ml) in the presence of
ACAT inhibitor (2 g/ml) either with DMSO or with ligand for LXR (2 M
GW3965) and RXR (100 nM LG268). After equilibrating the cholesterol
pools, cells were washed with PBS and incubated in DMEM containing
0.2% BSA in the absence or presence of ApoAI (15 g/ml) for 6 hr. Radioac-
tivity in the medium and total cell-associated radioactivity was determined
by scintillation counting. The data are presented as percent ApoAI-spe-
cific efflux.
Macrophage inflammatory response
After differentiation, AIM+/+ and AIM−/− bone marrow-derived macrophages
were placed in DMEM + 0.5% FBS with simvastatin and mevalonic acid for
8 hr prior to stimulation with DMSO or ligand for LXR (2 M GW3965) and
RXR (100 nM LG268) for 18 hr. Cells were then treated with or without LPS
(100 ng/mL) for 5 hr. Total RNA was extracted using Trizol reagent (Life
Technologies, Inc). QPCR (SYBRgreen) analysis was performed on an Ap-
plied Biosystems 7700 sequence detector.
Primers
Primers used for expression analysis are 5#-GCAGCTGGGCTGTACAAA-3#
and 5#-AGCGTTTCGGGATCTGAAT-3# for iNOS; 5#-AGAAGCTGTGGCAGCELL METABOLISM : MARCH 2005CTACCTG-3# and 5#-GGAAAAGAAGGTGCTCATGTCC-3# for IL-1b; 5#-CTG
CAAGAGACTTCCATCCAGTT-3# and 5#-GAAGTAGGGAAGGCCGTGG-3#
for IL-6; 5#-CAGCCAGATGCAGTTAACGC-3# and 5#-GCCTACTCATTGG
GATCATCTTG-3# for MCP-1; 5#-TTTGTTGGATCGTGTTTTTCAGA-3# and
5#-CTTCACAGCGGTGGGCA-3# for mouse AIM; 5#-GGTTTGGAGATGGT
TATACAATAGTTGT-3# and 5#-CCCGGAAACGCAAGTCC-3# for ABCA1.
Antibodies, immunohistochemistry, cytostaining
The following antibodies were used for immunohistochemistry: rat anti-
mouse F4/80 (Clone: CI:A3-1) (Caltag)+Cy-3 conjugated goat anti-rat IgG
(Chemicon) as a secondary antibody; mouse anti-α actin (for SMC; Clone:
1A4) (Sigma)+Cy-3 conjugated goat anti-mouse (Caltag); rat anti-mouse
CD31/PECAM-1 (Clone: MEC13.3) (BD Pharmingen)+Cy-3 conjugated goat
anti-rat IgG (Chemicon); rat anti-mouse CD106/VCAM-1 (Clone: M/K-2)
(CALTAG)+Cy-3 conjugated goat anti-rat IgG (Chemicon); CD68, FITC con-
jugated (BD Pharmingen); MOMA-2 (Accurate Chemicals)+FITC-conjugated
anti-rat IgG (Molecular Probes). Collagen was stained with Picrosirus Red
as described (Dolber and Spach, 1987). The anti-AIM polyclonal antibody
(SA-1) was generated by immunizing rabbits with His-tagged recombinant
AIM protein that was produced by Trichoplusia ni egg cells (HighFive cells;
Invitrogen) infected by a recombinant baculovirus (Miyazaki et al., 1999).
The SA-1 antiserum was detected with an Alexa Fluor 488 conjugated goat
anti-rabbit IgG (Molecular Probes) or rhodamine-conjugated goat anti-rab-
bit IgG (Jackson ImmunoResearch) as a secondary antibody. Paraffin-
embedded sections were first treated by Xylene and Ethanol to remove
paraffin, followed by a treatment by 0.02% Trypsin in 0.05 M Tris-HCl to
retrieve antigens, before the staining procedures, as described elsewhere.
Prior to antibody staining, sections were incubated with 5% skim milk, 2.5%
BSA in PBS-Tween and/or the Fc-blocker (rat-anti mouse CD16/CD32 anti-
body [BD Pharmingen]) in PBS-Tween to block the Fc receptor and nonspe-
cific antibody binding. Stained sections were analyzed by using a fluores-
cent microscope and an imaging analyzer (Nikon). RAW-LXRα stable cell
line was generated by retroviral transduction using a pBabe-puro based
expression vector as described (Venkateswaran et al., 2000). For cytostain-
ing of RAW-LXRα cells for intracelular AIM, cells were fixed with 3.8% (v/v)
paraformaldehyde in PBS for 15 min and then permeablized with 0.1% tri-
ton-X-100 in PBS for 10 min in room temperature. Cells were stained with
the SA-1 antibody for 60 min, followed by rhodamine-conjugated goat anti-
rabbit IgG from Jackson ImmunoResearch (West Grove, Pennsylvania) for
60 min in 10% FCS in PBS. Cells were then stained with by FITC-conju-
gated rat anti-mice CD68 for 30 min. To detect human AIM protein, human
left anterior descending coronary artery containing atherosclerotic plaque
was harvested at autopsy, snap-frozen, and stored at −80°C. After fixing
for 5 min in cold acetone, frozen sections (6 µm) were processed for immu-
nohistochemical staining. After three washes with ice-cold phosphate-buf-
fered saline (PBS), sections were blocked with 0.1% bovine serum albumin
in PBS containing nonimmune goat serum. Frozen sections were incubated
with the SA-1 antibody, followed by Alexa Fluor 488 conjugated goat anti-
rabbit IgG. Staining with nonimmune rabbit IgG (Dako) served as a negative
control. Slides were mounted in fluorescence mount with DAPI (Vector).
Statistical analysis
A two-tailed Mann-Whitney test was used to calculate p values. (**), p <
0.01; (*), p < 0.05.
Acknowledgments
We thank Drs D. Russell, H. Hobbs, J. Herz (Dallas), D. Mathis, and M.
Shimada (Boston) for helpful advice and critical reading of manuscript; Dr.
S. Ohnishi (Tokyo) for help in cholesterol profiling; the core histology facility
at UTSW (Dallas) and Dr. K. Miyake (Dallas) for technical assistance; Dr. T.
Kadowaki (Tokyo) for the kind gift of LG100153; and Dr. T. Willson (Glaxo-
SmithKline) for GW3965. We also appreciate Dr. E.K. Wakeland (Dallas) for
his kind advice about the genetic analysis of mice; S. Subramanian and
G. Westerfield (Dallas) for the help in preparing the manuscript. T.M. is sup-
ported by grants of NIH (RO1-AI050948A2, R21-AI050948), JDRF (1-2001-
581), ALF, PAF, and HHMI. D.J.M. and P.T. are investigators of the Howard
Hughes Medical Institute. P.T. is also supported by NIH grants (HL66088211
A R T I C L Eand HL30568), and P.A.E. is supported by an NIH grant (HL 30568). None
of the authors have a financial interest related to this work.
Received: November 17, 2004
Revised: February 15, 2005
Accepted: February 25, 2005
Published: March 15, 2005
References
Bookout, A.L., and Mangelsdorf, D.J. (2003). A quantitative real-time PCR
protocol for analysis of nuclear receptor signaling pathways. NURSA
e-Journal 1, ID1.11082003.11082001.
Cai, Q., Lanting, L., and Natarajan, R. (2004). Interaction of monocytes with
vascular smooth muscle cells regulates monocyte survival and differentia-
tion through distinct pathways. Arterioscler. Thromb. Vasc. Biol. 24, 2263–
2270.
Chawla, A., Boisvert, W.A., Lee, C.H., Laffitte, B.A., Barak, Y., Joseph, S.B.,
Liao, D., Nagy, L., Edwards, P.A., Curtiss, L.K., et al. (2001). A PPAR
gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol ef-
flux and atherogenesis. Mol. Cell 7, 161–171.
Colinayo, V.V., Qiao, J.H., Demant, P., Krass, K., Lusis, A.J., and Drake, T.A.
(2002). Genetic characterization of the Dyscalc locus. Mamm. Genome 13,
283–288.
Collins, J.L., Fivush, A.M., Watson, M.A., Galardi, C.M., Lewis, M.C., Moore,
L.B., Parks, D.J., Wilson, J.G., Tippin, T.K., Binz, J.G., et al. (2002). Identifi-
cation of a nonsteroidal liver X receptor agonist through parallel array syn-
thesis of tertiary amines. J. Med. Chem. 45, 1963–1966.
Cybulsky, M.I., and Gimbrone, M.A., Jr. (1991). Endothelial expression of a
mononuclear leukocyte adhesion molecule during atherogenesis. Science
251, 788–791.
Dolber, P.C., and Spach, M.S. (1987). Picrosirius red staining of cardiac
muscle following phosphomolybdic acid treatment. Stain Technol. 62, 23–
26.
Edwards, P.A., Kast, H.R., and Anisfeld, A.M. (2002). BAREing it all: the
adoption of LXR and FXR and their roles in lipid homeostasis. J. Lipid Res.
43, 2–12.
Febbraio, M., Podrez, E.A., Smith, J.D., Hajjar, D.P., Hazen, S.L., Hoff, H.F.,
Sharma, K., and Silverstein, R.L. (2000). Targeted disruption of the class B
scavenger receptor CD36 protects against atherosclerotic lesion develop-
ment in mice. J. Clin. Invest. 105, 1049–1056.
Feng, B., Zhang, D., Kuriakose, G., Devlin, C.M., Kockx, M., and Tabas, I.
(2003). Niemann-Pick C heterozygosity confers resistance to lesional necro-
sis and macrophage apoptosis in murine atherosclerosis. Proc. Natl. Acad.
Sci. USA 100, 10423–10428.
Gebe, J.A., Kiener, P.A., Ring, H.Z., Li, X., Francke, U., and Aruffo, A. (1997).
Molecular cloning, mapping to human chromosome 1 q21-q23, and cell
binding characteristics of Spalpha, a new member of the scavenger recep-
tor cysteine-rich (SRCR) family of proteins. J. Biol. Chem. 272, 6151–6158.
Geng, Y.J., and Libby, P. (2002). Progression of atheroma: a struggle be-
tween death and procreation. Arterioscler. Thromb. Vasc. Biol. 22, 1370–
1380.
Glass, C.K., and Witztum, J.L. (2001). Atherosclerosis. the road ahead. Cell
104, 503–516.
Groen, A.K., Bloks, V.W., Bandsma, R.H., Ottenhoff, R., Chimini, G., and
Kuipers, F. (2001). Hepatobiliary cholesterol transport is not impaired in
Abca1-null mice lacking HDL. J. Clin. Invest. 108, 843–850.
Haruta, I., Kato, Y., Hashimoto, E., Minjares, C., Kennedy, S., Uto, H., Ya-
mauchi, K., Kobayashi, M., Yusa, S., Muller, U., et al. (2001). Association
of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting
macrophage survival and enhancing phagocytotic function of macro-
phages. J. Biol. Chem. 276, 22910–22914.
Herz, J., Clouthier, D.E., and Hammer, R.E. (1992). LDL receptor-related212protein internalizes and degrades uPA-PAI-1 complexes and is essential for
embryo implantation. Cell 71, 411–421.
Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R., and Mangelsdorf, D.J.
(1996). An oxysterol signalling pathway mediated by the nuclear receptor
LXR alpha. Nature 383, 728–731.
Joseph, S.B., Castrillo, A., Laffitte, B.A., Mangelsdorf, D.J., and Tontonoz,
P. (2003). Reciprocal regulation of inflammation and lipid metabolism by
liver X receptors. Nat. Med. 9, 213–219.
Joseph, S.B., Bradley, M.N., Castrillo, A., Bruhn, K.W., Mak, P.A., Pei, L.,
Hogenesch, J., O'Connell, R.M., Cheng, G., Saez, E., et al. (2004). LXR-
dependent gene expression is important for macrophage survival and the
innate immune response. Cell 119, 299–309.
Kelly, M.A., Low, M.J., Phillips, T.J., Wakeland, E.K., and Yanagisawa, M.
(2003). The mapping of quantitative trait loci underlying strain differences in
locomotor activity between 129S6 and C57BL/6J mice. Mamm. Genome
14, 692–702.
Kockx, M.M., and Herman, A.G. (2000). Apoptosis in atherosclerosis: bene-
ficial or detrimental? Cardiovasc. Res. 45, 736–746.
Kolodgie, F.D., Narula, J., Burke, A.P., Haider, N., Farb, A., Hui-Liang, Y.,
Smialek, J., and Virmani, R. (2000). Localization of apoptotic macrophages
at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 157,
1259–1268.
Kuwata, K., Watanabe, H., Jiang, S.Y., Yamamoto, T., Tomiyama-Miyaji, C.,
Abo, T., Miyazaki, T., and Naito, M. (2003). AIM inhibits apoptosis of T cells
and NKT cells in Corynebacterium-induced granuloma formation in mice.
Am. J. Pathol. 162, 837–847.
Laffitte, B.A., Repa, J.J., Joseph, S.B., Wilpitz, D.C., Kast, H.R., Mangels-
dorf, D.J., and Tontonoz, P. (2001). LXRs control lipid-inducible expression
of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl.
Acad. Sci. USA 98, 507–512.
Li, A.C., and Glass, C.K. (2002). The macrophage foam cell as a target for
therapeutic intervention. Nat. Med. 8, 1235–1242.
Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868–874.
Libby, P., Geng, Y.J., Aikawa, M., Schoenbeck, U., Mach, F., Clinton, S.K.,
Sukhova, G.K., and Lee, R.T. (1996). Macrophages and atherosclerotic
plaque stability. Curr. Opin. Lipidol. 7, 330–335.
Littlewood, T.D., and Bennett, M.R. (2003). Apoptotic cell death in athero-
sclerosis. Curr. Opin. Lipidol. 14, 469–475.
Liu, J., Thewke, D.P., Su, Y.R., Linton, M.F., Fazio, S., and Sinensky, M.S.
(2005). Reduced macrophage apoptosis is associated with accelerated ath-
erosclerosis in low-density lipoprotein receptor-null mice. Arterioscler.
Thromb. Vasc. Biol. 25, 174–179.
Lusis, A.J. (2000). Atherosclerosis. Nature 407, 233–241.
Mallat, Z., Hugel, B., Ohan, J., Leseche, G., Freyssinet, J.M., and Tedgui,
A. (1999). Shed membrane microparticles with procoagulant potential in
human atherosclerotic plaques: a role for apoptosis in plaque thrombogeni-
city. Circulation 99, 348–353.
Maxwell, K.N., Soccio, R.E., Duncan, E.M., Sehayek, E., and Breslow, J.L.
(2003). Novel putative SREBP and LXR target genes identified by microarray
analysis in liver of cholesterol-fed mice. J. Lipid Res. 44, 2109–2119.
Mehrabian, M., Wong, J., Wang, X., Jiang, Z., Shi, W., Fogelman, A.M.,
and Lusis, A.J. (2001). Genetic locus in mice that blocks development of
atherosclerosis despite extreme hyperlipidemia. Circ. Res. 89, 125–130.
Miyazaki, T., Hirokami, Y., Matsuhashi, N., Takatsuka, H., and Naito, M.
(1999). Increased susceptibility of thymocytes to apoptosis in mice lacking
AIM, a novel murine macrophage-derived soluble factor belonging to the
scavenger receptor cysteine-rich domain superfamily. J. Exp. Med. 189,
413–422.
Paigen, B., Nesbitt, M.N., Mitchell, D., Albee, D., and LeBoeuf, R.C. (1989).
Ath-2, a second gene determining atherosclerosis susceptibility and high
density lipoprotein levels in mice. Genetics 122, 163–168.
Peet, D.J., Turley, S.D., Ma, W., Janowski, B.A., Lobaccaro, J.M., Hammer,CELL METABOLISM : MARCH 2005
Deletion of AIM decreases atherosclerosis developmentR.E., and Mangelsdorf, D.J. (1998). Cholesterol and bile acid metabolism
are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell
93, 693–704.
Plump, A.S., Smith, J.D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft,
J.G., Rubin, E.M., and Breslow, J.L. (1992). Severe hypercholesterolemia
and atherosclerosis in apolipoprotein E-deficient mice created by homolo-
gous recombination in ES cells. Cell 71, 343–353.
Repa, J.J., and Mangelsdorf, D.J. (2000). The role of orphan nuclear recep-
tors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol.
16, 459–481.
Salvayre, R., Auge, N., Benoist, H., and Negre-Salvayre, A. (2002). Oxidized
low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta 1585,
213–221.
Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K.,
Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997). A role for
macrophage scavenger receptors in atherosclerosis and susceptibility to
infection. Nature 386, 292–296.
Tabas, I. Suppl. 1(2004). Apoptosis and plaque destabilization in atheroscle-
rosis: the role of macrophage apoptosis induced by cholesterol. Cell Death
Differ. 11, S12–S16.
Tangirala, R.K., Rubin, E.M., and Palinski, W. (1995). Quantitation of athero-
sclerosis in murine models: correlation between lesions in the aortic origin
and in the entire aorta, and differences in the extent of lesions betweenCELL METABOLISM : MARCH 2005sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid
Res. 36, 2320–2328.
Tangirala, R.K., Bischoff, E.D., Joseph, S.B., Wagner, B.L., Walczak, R., Laf-
fitte, B.A., Daige, C.L., Thomas, D., Heyman, R.A., Mangelsdorf, D.J., et
al. (2002). Identification of macrophage liver X receptors as inhibitors of
atherosclerosis. Proc. Natl. Acad. Sci. USA 99, 11896–11901.
Tontonoz, P., and Mangelsdorf, D.J. (2003). Liver X receptor signaling path-
ways in cardiovascular disease. Mol. Endocrinol. 17, 985–993.
Tupin, E., Nicoletti, A., Elhage, R., Rudling, M., Ljunggren, H.G., Hansson,
G.K., and Berne, G.P. (2004). CD1d-dependent activation of NKT cells ag-
gravates atherosclerosis. J. Exp. Med. 199, 417–422.
Valledor, A.F., Hsu, L.C., Ogawa, S., Sawka-Verhelle, D., Karin, M., and
Glass, C.K. (2004). Activation of liver X receptors and retinoid X receptors
prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci.
USA 101, 17813–17818.
Venkateswaran, A., Laffitte, B.A., Joseph, S.B., Mak, P.A., Wilpitz, D.C., Ed-
wards, P.A., and Tontonoz, P. (2000). Control of cellular cholesterol efflux by
the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 97,
12097–12102.
Welch, C.L., Bretschger, S., Latib, N., Bezouevski, M., Guo, Y., Pleskac,
N., Liang, C.P., Barlow, C., Dansky, H., Breslow, J.L., and Tall, A.R. (2001).
Localization of atherosclerosis susceptibility loci to chromosomes 4 and
6 using the Ldlr knockout mouse model. Proc. Natl. Acad. Sci. USA 98,
7946–7951.213
